
Siemens Healthineers AG
SEMHF | OTC
$47.69
$0.00 (-0.01%)
At close: Oct 30, 2026, 3:13 PM ET
$47.69
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 4:00 PM ET
Company Profile
Siemens Healthineers AG, along with its affiliated companies, offers a global portfolio of diagnostic and therapeutic solutions, which it designs, produces, and markets to healthcare organizations worldwide. The company's operations are structured into four distinct divisions: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging division specializes in advanced medical imaging technologies, encompassing magnetic resonance imaging (MRI), computed tomography (CT), X-ray equipment, molecular imaging techniques, and ultrasound systems. Within the Diagnostics division, the focus is on supplying in-vitro diagnostic solutions and services to healthcare professionals across various settings, including laboratory, molecular, and point-of-care environments. It also delivers laboratory workflow optimization tools and informatics solutions. The Varian segment is dedicated to oncology, furnishing cancer care technologies, comprehensive solutions, and support services to hospital and clinic oncology departments. This includes advanced workflow optimization through technology, expert clinical services and consultancy, as well as digital tools and applications designed to streamline and oversee patient treatment and therapy protocols. The Advanced Therapies division delivers products engineered to facilitate image-guided, minimally invasive procedures in fields such as cardiology, interventional radiology, and surgery. Its offerings extend to angiography systems and mobile C-arms, notably featuring a robotic-assisted platform for endovascular interventions involving coronary and peripheral vasculature. Beyond these core segments, Siemens Healthineers also offers a suite of supplementary services. These comprise managing equipment performance, clinical training and e-learning programs, asset management, and outsourced departmental services for both laboratories and wider healthcare institutions, alongside consulting and digital health solutions. Headquartered in Erlangen, Germany, Siemens Healthineers AG functions as a subsidiary of Siemens Aktiengesellschaft.
Key Executives
| Name | Position |
|---|---|
| Bernhard Montag | President, Chief Executive Officer & Chairman of Management Board |
| Jochen Schmitz | Chief Financial Officer & Member of Management Board |
| Astrid Kristine Ploss | Member of Supervisory Board, Head of Legal Advanced Therapies & Head of Legal Technology Excellence |
| Christian Klaussner | Executive Vice President of Finance |
| Darleen Caron | Chief Human Resources Officer, Labor Director & Member of Management Board |
| Elisabeth Staudinger | Member of Management Board |
| Jerry Wang | Head of China |
| Marc Koebernick | Head of Investor Relations |
| Matthias Kraemer | Head of Corporate Communications |
| Sharon J. Bracken | Head of Diagnostics |
Siemens Healthineers AG

| Country | Germany |
| IPO Date | Aug 4, 2023 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 74,000 |
| CEO | Bernhard Montag |
Contact Details
Siemensstr. 3 Forchheim,
BV 91301 Germany
Stock Details
| Ticker Symbol | SEMHF |
| Exchange | OTC |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | n/a |
| ISIN Number | DE000SHL1006 |
| SIC Code | n/a |
Recent News
- 1 month ago / businesswire.comSun Nuclear Announces Validated Adaptive QA Solution in Support of New Radiotherapy System, Accela, by Siemens Healthineers
- 2 months ago / seekingalpha.comSiemens Healthineers: Successful Investment, Updating For H2 2026
- 3 months ago / wsj.comSiemens Healthineers Cuts Revenue Outlook on Diagnostics Weakness
- 3 months ago / reuters.comSiemens Healthineers cuts revenue forecast citing diagnostics weakness
Add to Watchlist
Select watchlists to add or remove SEMHF